Company profile
Micropore Technologies - Home page
Micropore Technologies - the world's leading authority on micro particle engineering using scaleable membrane emulsification and encapsulation technology
Updated 06 Jun 2026 16:52
Financial period: 1 Oct 2023 to 30 Sep 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
AA | Transaction MzUxMjc1MDg5OGFkaXF6a2N4
Published 26 Mar 2026 11:23
Last accounts made up date
Last confirmation statement made up date
TM01 | Transaction MzQ0MTkyMjE4N2FkaXF6a2N4
Published 04 Nov 2024 05:08
RESOLUTIONS | Transaction WURDVURPQUFhZGlxemtjeA | Paper/PDF filed
Published 08 Oct 2024 06:30
SH01 | Transaction MzQzODU1MDg3NmFkaXF6a2N4
Published 07 Oct 2024 07:53
Company registered at Companies House
1 May 2024 to 31 Mar 2026
The project led by the UK SME Micropore Technologies (Micropore), supported by Northumbria University, Strathclyde University and Teesside University, aims to develop and validate a new approach to speed process development using machine learning. The area of focus is the encapsulation of genomic material (RNA) in protective nanoparticles. The development...
1 Aug 2023 to 31 Jul 2025
The RAP-IDD project (Rapid Development of Intracellular Drug Delivery Innovations), led by the UK SME Micropore Technologies (Micropore), supported by SME Labman Automation (Labman) and CPI, aims to develop and validate a new technology platform to encapsulate genomic material (RNA and DNA) in protective nanoparticles and integrate this with high-throughp...
1 Dec 2022 to 31 Jul 2024
**Need** The UK is currently undergoing a **cost of living crisis**. **Soaring energy prices** and the war in Ukraine are highlighting both **energy security** and **fuel poverty** issues, with **3.16m** UK households (13.2%) **living in fuel poverty** (BEIS, 2020) choosing between eating and heating. This was estimated to increase to 5m fuel poor homes w...
1 Nov 2022 to 31 Oct 2025
This project aims to transform a batch process for the manufacture of controlled release injectable drugs into a continuous process with appropriate control mechanisms to ensure robust, consistent product using methods that comply with FDA and other regulators' requirements. This has never been achieved before. It is particularly important for patient car...
1 Nov 2017 to 31 Jul 2021
Microcapsules are ubiquitous in everyday life and are found in products used in crop protection, drug delivery, personal care, cosmetics etc. All microcapsules contain an active ingredient protected by the capsule shell for a multitude of purposes including safety, taste masking, stability and targeted delivery. To improve the performance of the capsule (...
1 Dec 2013 to 30 Nov 2014
A research-based feasibilty study using a new manufacturing process to investigate production of specialist formulated particles in a cost-effective and high throughput process with highly defined particle properties. The innovative aim of the project is to use continuous membrane emsulsification as a means to formulate particles using physical as well as...
1 Apr 2013 to 31 Mar 2017
Awaiting Public Project Summary
1 May 2011 to 31 Jul 2011
Awaiting Public Summary
